Search

Displaying results 8171 - 8180 of 10000 in total
  1. Drug

    PT217

    go.drugbank.com/drugs/DB18472
    Investigational

    PT217 is a bispecific Antibody against DLL3 and CD47

  2. Drug

    ASP-2138

    go.drugbank.com/drugs/DB18473
    Investigational

    ASP-2138 is a bispecific antibody directed against CLDN18.2 and T cell receptor complex CD3

  3. Drug

    VBI-1901

    go.drugbank.com/drugs/DB18476
    Investigational

    VBI-1901 is a bivalent cytomeglaovirus gB/pp65 enveloped virus-like particles

  4. Drug

    Rodatristat

    go.drugbank.com/drugs/DB18478
    Experimental

    Synonyms: (3s)-8-(2-amino-6-((1r)-1-(5-chloro(1,1'-biphenyl)-2-yl)-2,2,2-trifluoroethoxy)-4-pyrimidinyl)-2,8-diazaspiro(4.5)decane-3-carboxylic acid, (3s)-8-(2-amino-6-((1r)-1-(5-chloro(1,1'-biphenyl)-2-yl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)-2,8-diazaspiro(4.5)decane-3-carboxylic acidCategories: Heterocyclic Compounds, 1-Ring
  5. Drug

    Heparan-N-sulfatase (human, recombinant)

    go.drugbank.com/drugs/DB18483
    Investigational

    Recombinant human heparan-N-sulfatase (rhHNS) is under investigation for the treatment mucopolysaccharidosis type IIIA.

    Synonyms: Recombinant human heparan-N-sulfatase, Heparan-N-sulfatase (human, recombinant)
  6. Drug

    ALT-P1

    go.drugbank.com/drugs/DB18485
    Investigational

    ALT-P1 is a long-acting recombinant human growth hormone fused to an alpha1-antitrypsin variant. It is under investigation for the treatment of growth hormone deficiency.

  7. Drug

    KT-253

    go.drugbank.com/drugs/DB18487
    Investigational

    KT-253 is a selective heterobifunctional small molecule degrader of mouse double minute 2 (MDM2).

  8. Drug

    DMP-777

    go.drugbank.com/drugs/DB18488
    Experimental

    DMP-777 is a selective inhibitor of polymorphonuclear leukocyte (PMN) elastase.

    Categories: Heterocyclic Compounds, 1-RingSynonyms: 1-AZETIDINECARBOXAMIDE, N-((1R)-1-(1,3-BENZODIOXOL-5-YL)BUTYL)-3,3-DIETHYL-2-(4-((4-METHYL-1-PIPERAZINYL)CARBONYL)PHENOXY)-4-OXO-, (2S)-
  9. Drug

    Aficamten

    go.drugbank.com/drugs/DB18490
    ApprovedInvestigational

    Aficamten is a cardiac myosin inhibitor. … [L54788] Approved by the FDA on December 19, 2025, aficamten is indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C19 SubstratesSynonyms: (R)-N-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)- 1-methyl-1H-pyrazole-4-carboxamide, (R)-N-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-1-methyl-1H-pyrazole-4-carboxamide
  10. Drug

    LTI-03

    go.drugbank.com/drugs/DB18491
    Investigational

    LTI-03 is a caveolin-1 Scaffolding Domain 7-Mer

    Synonyms: L-threonine, l-phenylalanyl-l-threonyl-l-threonyl-l-phenylalanyl-l-threonyl-l-valyl-